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Introduction 
The substantial progress that Indian Industry has made in the ilast 
decades can be at least partly attributed to the strength' of the techno-
logical skills of its R&D personnel. Although it is tommonlysaid 
that India has the third largest contingent of scientists and engineers, 
it is now well recognized that the percentage of those aetually engaged 
in real technological tasks is small. The investment of Indian Industry 
in R&D is also a\~efully small (less than H~). In the light of these 
facts, the contribution of in-house R &: D is significant indeed; it 
could be still better if appropriate investments and inputs are provided. 
This article will comr.lent on those in relation to the Chemical Industry, 
especia 11 y the Drugs and Pestic ides sectors wi til \~hich the author has 
been intimately associated for several years. 
Perspective plan for the Chemical Industry 
The Chemical Industry in India constitutes an important and dynamic 
segment with good growth rate in production for local consumption but 
more significantly fQr exports. The export of plastics for ex~mple 
valued at Rs.129 crores in 1988-89 is expected to increase to Rp.400 
crores by the end of the 8th plan. Exports of bther chemicals a~d rela-
ted products which are presently Rs. 1280 crores can go upto Rs.~ 4000 
crores by 2000 A.D. 
Realizing the need for formulating a perspective plan for the Chemical 
Industry, the Indian Government had appointed an apex 'committee to 
enunciate one upto the year 2000 A.D. .. This committee constituted fnur 
subgroups in the area of Inorganic chemicals, Organic chemicals,. Dye~ 
stuffs and Pesticides. These comn)i ttees had interactions with various 
;experts awJ industry associations. Th9Y stujieri in detail the dernand--' 
supply pattern of each of the major chclnica1.s anrJ other "importa,)'fTssue"s"-""" 
like growth rate, investments required in the industry, export potential. 
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the present technology, future upgradation and environment pollution. 
The role and contributions of R&D have been also considered. 
Since the Chemical Industry -is an essential one in the core sector, 
the perspective plan has continuing validity. We shall now look at 
the various opportunities for contribution by R&D in attaining the_ 
goals of this plan. 
R&D assignments in Chemical Industry: 
Inorganic Chemicals 
The current status of technology in this group is mostlysatisfacto~y; 
where necessary in specific cases, knowholtJ can be brought in. At the 
moment, caustic soda and calcium basic diphosphate seem to have,exp6rt 
potential. The role of in-house R&D could be to improve the efficiency 
of plant operations through improved equipment designing, energy conser-
vation, use of better materials of construction, effluent treatment 
and pollution abatement. Other specific R&D tasks coul-i be (i) cost _ 
'reduction in the process for sodium tripolyphosphate, (ii) developm~nt 
of liquid hydrogen manufacturing technology, (iii) development of new 
products like flame-retardant chemicals from phosphorus and inorganic 
----- ---_._ .. __ ... -
catalysts such as Zeolites and thbse required in the manufacture of 
nitric acid. 
Dyestuffs 
The Indian Dyestuff Industry represents the highest develoR~nt of chemi-
cal technology and R&D achievements and forms an important link-·-in 
the chain of other essential chemical industries. It was thriving well 
until it was affected by internal demand recession; nevertheless this 
was offset by exports. Its production value is in excess of Rs.400 
crores. The export _ COmPonent has been very high, amounting to Rs. 215 
crores in 1987-88. The target for 1988-89 at Rs.350 crores has been 
probably realized. 
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R&D has contributed in numerous ways - improvement in quality /yield'\ :. ", , , !.' '. . .. :,' ~ 
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and product i vi t y, rjev210plnent of Iilore el:LJllomic--- a Iten1a·ti:VF~·_-jJroc~s·_··"~·''"~·' 
and of new products. ~Jeeds to be arldressed in' the future: ate 'prmiucing 
newer dn:1 Inore economic dyestuffs with ease of app 1. icat ion, '1 igher fixa-
tion efficiency, fastness properties and superior colour yields. 
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R&D can also contribute. to energy conservati0n and particularly pq1lu-· 
tion containment. It must be noted that the export performa~ce ~f...~~r ..... " ... " 
dyestuff industry is probably helped by the less stringent (at lea~t 
in practice) envirorvnent regulations in our country. 
Organic Chemicals 
Although drugs and pesticides (as also dyestuffs) should logically come 
under this group, they are discussed separately as they are ~elative1y 
high technology, high value speciality chemicals. This group then is 
- _ .. _--- --_.. _. -
comprised of bulk, cOllVTlodity chemicals used as basic building blocks 
and required in very large tonnage such as ethyl alcohol, acetic acid, 
acetone etc. Among these chemicals,' some like phthalic anhydride and 
ethyl alcohol have been identified to have export potential. 
I I I . 
The organic chemical industry has reached a size of near self -sufficiency. 
in terms of technologies. for most of the important chemicals. I,/hile 
for some of the chemicals technology has been developed by indigenous 
-., .-~---~-- .:-:--
'R & 0, it has been imported for some others and absorbed by industry. 
Some of the tasks identified .for R&D work are; 
i) Energy conservation or reduction in existing processes. 
'ii) Assimilation and improvement of imported technology. 
iii) Continuation of efforts to increase yields and reduce raw materi?l 
consumption and to SUbstitute imports with indigenous mat~rials. 
iv) Development of catalysts such as those required in the manufactui'e 
-I of acetic acid, aniline, formaldehyde, pentaerythritol and phthalic 
anhydride. 
v) Development of nonphosgene routes for polyurethene monomers and 
polymer alloys. 
Drugs, Pharmaceuticals. 
Starting from humble beginnings around the time of independence, the 
Indian Pharmaceutical Industry lias made tremendous progress in' four 
. - '-. : 
decades. In 1988-89, the industry produced with a capi tal investment 
. .. - .~,.' ., 
of Rs.750 crores, hulk drugs worth Rs. S3rJ croresused ir"T(ifiiiQTatTbn~;" ......... ~ .. 
of Rs ~ 2090 crores. The export contribut ton was substantial -
.. .=:.::..-.::" .. - .. 
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Rs.243 crores of bulk drugs and Rs. 157 crores of forrrulations, totalling 
upto Rs.400 crores; the projection for bulk drugs is Rs.425 crotes for 
1989-90. At the end of the 8th five-year plan, it is envisaged -that" 
formulations to the, value of Rs.6,610 crores (at 1989 pricesL will be 
produced from Rs.1,350 crores of bulk drugs. The anbitious target for 
2000 A.D. is R.16,000 crores of formulations. The industry employs at 
least 2,nn,080 persons directly and almost 10,00,000 indirectly in rela-
ted or ancillary industries. 
A large measure of credit for this performance must be given to the 
technologiclal prowess of the industry and the capabilities of its 
R It 0, as well,23 to the Government's thrust for indigenisation ami 
hl)Jort subst i tution. 
In-house R&D alone or occassionally with the assistance of CSI~ Labora-
tories has provided process know-how for bulk drugs and fiJrrnulatio~s. 
Multina: 1011315 also brought in expert iSf~ and technology which have 
been assimilated, adapted and improved upon. Thus indigenous production 
based upon Indian R&D is repoited for top~sellingworld class drugs. 
Synthesis of complicated molecules requiring multistep processes, micro..;.' 
. biological transformation products, semisynthetic -antibiotics using 
immobilized enzymes and chiral molecules using conventional resolving 
agents is a spectacula~.achievement of the Indian R&D. A number of 
bulk drugs using GMP condl tionsare exported to the l!Jest. In fact India 
is the largest manufacturer of a few of these drugs. 
In-house R&D can make more significant contritiutions in the futu.re 
as follows: 
i) International patents on 14 out of 15 top-sellin~ drugs are expiring 
by 1995. hie can take ad\.(antage of this by developing proc,esses for 
those for which we still do not have one and increase our exports. 
i 1) ou, pm,," 55 in p me ess deve 1 apmen t. is adapt; ve . anL~L~~l. ! ".~:: 
rleally i.nnovative IJ[ocesses shoulrjhe ailned at, which I'Jould be ·intl=r:\3-" 
tionally patentable and can be exploited cOlomercially; 
iii ) . - .. -._ ... _ .. - .. Ille should take advantage of modern developments in OrganIc-syrll:he-
sis like high pressure chemistry and sonochemistry where appl icahl:e. 
Induction of ::>ptical activity using hOI'~ol)enous chiral ::atdlysts or chiral 
, 
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auxiliaries has to be contemplated on an industrial scale. 
i v)' In the exploitation of bio-technology. in-house R 1 0 sh~uld- st~Il 
concentrate on fermentation reactions especially for antibiotics, and 
chemicals like vitamin C and citric acid. Inspite of an early, start, 
the expertise 'in this technology in the country is far from satisfactoty. 
Use of 'natural or 'artificial' enzymes for organic reactions especially 
to produce chi.ral molecules from prochiral precursors is a laudable 
objective. IlklUe vaccines for diseases like Malaria, Filariasi.s and 
Leprosy could be pursued by botli industrial and academic research, more 
sophisticated rONA technology for esoteric, therapeutic peptides like 
tissue ~las~inogen activator is best left to the latter. 
v) In the field of formulations, special R&D efforts are needed to 
introduce recent advances like trans -dermal patches, zero order delivery 
systems and liposome and antibody tagged preparations for targeted 
attac i<, bearim:J in minrJ, of course, that these should be cost effective. 
Pesticides 
The use of pesticides in India started on a small scale around 1948 
by importing DDT for malaria control and then 8HC for locust control. 
Pesticide use in agriculture was initiated for the first time in 1949. 
Indigenous production started in 1952 with the setting up of DDT ~nd 
8HC plants in Delhi in 1954. From then the industry has made giant stri-
des and contributed in a large measure to the green revolution. ;1n 
1986-87, the industry had an ihstalled capacity for the production of 
1,02,015 metric tonnes of pesticides for agricultural and pubHc health 
, . . 
purposes and produced 56186 MT at a capac! ty utilisation-of-55~.· Jhe 
demand forecast for 19q4-95 is 1,30,nnO fYIT and for 2000 A.D. 1,52,000 
MT. The turnover of the industry in 1988-89 was Rs. 650 - 700 cror~s; 
it had an export component of around Rs. 40 crores; ililport was of a sma-
ller magnitude. 
As in other fine chemical industries, the pesticides industry enj~y-s 
IJOO:1 technological s t L'l~nlJth rju~t:lJ the :1 & 0 oJjJabit tt:tn"'·;'·-·"Du~·"" ~."':"'-'''' ~. 
acknowledgement must also be given to the help it has obtained 'frOm 
CSIR laboratories. Thanks to these, toda)' In:Ha is the largest 
manufacturer of basic pesticide chemicals among the Afro-Asian countries 
, 
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barring Japan. Of the 126 pesticides registered in the - countJ;:Y,. 57 
are manufactured locally ,most oftherh' based cirl indigenous technolog;;::.: ., ..... " 
In fact, in one case, the country has the. distinction of developipg 
a non-lethal route to a herbicide which is exported successfully. R 
& 0 has also been able to take care of the needs of conventional form~-
lations like emulsified concentrates, wettable powders, dusting formu-
lations ~nd in some cases granules. 
Some of the identified tasks for R&D in the near future are: 
i) Oevelop,nent of inrliqenous technolofJles for a fel~ more pesticides. 
U'<e aceiJhate, amitraz, newer synthetic pyrt:~throids, i1clller fUl1ljal il1li.j~­
zoles like propiconazole and potent sulphonyl urea herbicides li~e 
c~lorosulfuron. R&D should specially concentrate on pesticides. which 
are specific to pests ( e.g. chitin synthesis inhibitor) ami non-toxic 
t:J hUln3llS. 
ii) Development of newer processes for existing pesticides with a view 
to minimise, if not, eliminate the strain on the eco system and hazards 
to humans, ego non MIC route to' methyl'carbamates like carbaryl. 
iii) Investigating and utilising our plant resources some of which 
. have pesticidal properties. 
iv) Initiate research in relevant biotechnological areas like biological 
control of insects and building up resistance to herbicides in treate1 
plc;mts. 
v) Study and adaptation of modern formulation techniques which result 
in application of lesser q~antities for achieving desired levels of 
control. Some developments are: 
Suspoenulsion~, microemulsions, multiple emulsions" suspen-
sion concentrates, water-dispersible granules and controll~d 
release formulations. 
:, I., ., 
From development to discovery research - a plea :;~r~"' 
. i . 
Tilt! rJ~,:;dlli':; of .3 hr'J~ crJU'i1try 1 i!('.J .l)Ur~j :tJLt~'.1-·V3St-;)iJYrJ·t~·'~·OT1",·-iTI·"""--·"-"""--
tenns of hUillan health needs ~"'i aiJrlcul tural crop protection. a'ri Lit;;jc, , 
diverse ani ill sOlile C,~SlJS specific. orl the other hanri, our i.nriustri'es 
1'n .these areas are quite advanced and backed up with necessary sId lled 
q & D people ani infra structure. It is time therefore to consirlei" 
-.:"=-.--:...: .. 
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Basic research for new drugs 
The international cost of developing of a new drug is very high (Rs. 50-100 . 
, ' .. ._ ... ~ ... ~L·<- .. _ .... ~., ........ , .... ," 
crores), but the market itself is very large (Rs. 1,70,000 crores in 1$7). 
There is reason to believe that development costs of a new' drug in India 
need not be that high. Our efforts will become viable if a new discovery 
is aimed at serving local needs as well as capturing a share Df the world 
market. We have some of the skills ~mdexpertise needed for the task' but 
. r" ..• , . -._ .. _ •.. _ _ .. _. ____ :--~. __ . __ . __ .... __ - I 
others can be acquired. Additional investments may be needed. Of the' 
three important institutions engaged in this research, two are in: the 
private sector and the third is' a CSIR laboratory. A few others in the 
private sectot have been closed down for various reasons. New incentices 
to private industry and possibly a few more institutions in!he private . 
sector are needed. Collaboration among them will bring down the·'c'osts •. · _'. 
JiI In any event, licensing to or co-development with a multinational groLlp 
is indispensable for the success of this venture which will involve filing . 
international patents and world-wide marketing. 
Five major areas are suggested for this kind of undertaking on the basis' 
of national relevance and international importance : 
Antibacterials/antiinfectiv~s - $ 13.6 billions. 
12% of the world market in 1987;more than Rs. 
400 crores in India in 1988 at about 20% of the market. 
Cardiovascular agents - $ 16 billion. 
Nonsteroidal antiinflammatory agents - $ 5.3 billion 
Antiulcers $ 4.6 bill-ion 
Zantac alone sold for $ 1.48 billion in 1987 and now 
sales are in excess of two billion. 
Anticancers $ 3.9 billion. 
" ~ .. '. 
"1'" 
Apart from these, malaria',·' fialariasis and leprosy 'are""'l'OC'at"prolil:'ems'K~' 
needing attention. Fertility control is also a major issue. 
, I 
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Basic research for new pesticides 
The discovery and development of a new pesticide is just as cos,tlyand 
time consuming as a drug and en~ails a similar multidisciplinary approach. 
Nevertheless such an undertaking will be w~)rthwhile in India because of 
a large and growing market and specific needs ofplants.l;lnder .. Pl-g'._?,9I;9: .... -. 
climatic conditions. Additionally,' these can be targeted at a wodd~id~·'::::"--,,~ 
market of twenty billion dollars. 
Success of the approach will again involve investments in the private 
and public sector and collaborative efforts among these and will require 
further, penetration of the international market through multinational 
companies, with appropriate pqtent protections. 
In the context of development of both new plesticides and drugs, we should' 
well bear in mind the success of Japanese science. Although a reliatively 
late comer in the field of new drugs, Japan has the greatest number of 
introduction of new chemical entities as drugs (14/52 in 1988) ~ Many 
of these have been licensed to multinationals. Similarly, Japan has had 
resounding success in developing new pesticides like fenvalerate, MTI 
500 and Cartap. 
Measures to give new fillip to in-house R&D 
The following will go a long way to strengthen Indian R&D which will lead 
to increased contribution : 
i. New tax incentives/grants to private industry to- start 
and sustain R&D activities, especially basic research 
for new molecules. Even pricing policies and control 
mechanisms need to be looked at freshly to ensur'e ade-
quate profitability for affording 9uch investments:~' 
ii. Removal of import duty on R&D equipment and rea~onable 
quantities of fine chemicals - In house R&D laborato-
of equipme~t com~' 
r ies get 
pared to 
ssors. 
much 
CSIR 
purchase 
funded 
less money for 
labora tor ies or 
.... - \" 
uni v'ersit";; ~'profe~ 
: : ~ :.J.~': { 
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iii. Centrally funded lib,rary 
fa c ilii i~'~ "~~ d':'''-''i'~;f~'f'~'~ 'ti'~-~'" . 
'r-"" ;. ".- -. -.~. :" -" 
retrival systems ... in industrial"belts. 
unaffordable t~ individual R&D units. 
~ .. • I 
iv. Adequate ·monetary compensation for .industrial sciehtist~­
this is now lagging behind CSIR pay scales • 
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·'v. More wide-spread recognition of achievements of R&D . .. -......... :..,:,jl:.~ , ................... _ .. . 
scientists in terms of honours (there are. very few, none equivalent 
o)~. . .••• _ 
to the Bhatnagar Prize), fellowships (equivalents of FASe or FNA), 
enlistment to committees (fewer get into these compared to University 
or CSIR scientists) and enrollment into foreign delegations or 
exchanges. 
vi. More widespread exchanges ~ong in-house R&D scientists, 
academic and CSIR people and visiting lecturership at graduate/post 
graduate schools. 
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